Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-30

FDA Approved: SACUBITRIL AND VALSARTAN — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved Biocon Pharma Inc.'s original application for a generic sacubitril/valsartan tablet, enabling a generic version of the heart failure medication to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril and valsartan (sacubitril/valsartan)

Snippet

ORIG AP for SACUBITRIL AND VALSARTAN (SACUBITRIL AND VALSARTAN)